ETFdb Realtime Rating & Analyst Report for PPH
PPH is a passive ETF that seeks to replicate the Market Vectors US Listed Pharmaceutical 25 Index. The Index is a rules-based index intended to track the overall performance of 25 of the largest U.S. listed, publicly traded pharmaceutical companies.
| ETFdb Category | Expense Ratio | Inception Date | Issuer | Structure | YTD Return * |
|---|---|---|---|---|---|
| Health & Biotech Equities | 0.35% | 2011-12-20 | Van Eck | ETF | +1.77% |
* As of 05-24-2012
PPH Realtime Rating: By Metric
| Metric | Metric Realtime Rating | A+ Metric Rated ETF |
|---|---|---|
| Liquidity | A | XLV |
| Expenses | A- | XLV |
| Performance |  |
|
| Volatility | |
|
| Dividend | |
|
| Concentration | |
|
The first adjacent table gives investors an individual Realtime Rating for PPH on several different metrics, including liquidity, expenses, performance, volatility, dividend, and concentration of holdings. The "A+ Metric Rated ETF" field, available to ETFdb Pro members, shows the ETF in the Health & Biotech Equities ETFdb Category with the highest Metric Realtime Rating for each individual field.
PPH Realtime Rating: Overall
| ETFdb Rating Type | Overall Rating | A+ Overall Rated ETF |
|---|---|---|
| Realtime Rating (Overall) | |
|
The second table shows the overall Realtime Rating for PPH, as well as the A+ Overall Rated ETF in PPH's Category. To view information on how the ETFdb Realtime Ratings work, click here.
ETFdb Analyst Report for PPH
This ETF is one of several options for achieving exposure to the pharma industry, a corner of the health care market that is capable of delivering big returns but that also comes with some unique risk factors. Given this investment objective, PPH is probably more useful for those looking to achieve...
Pro Membership Required to Continue Reading
To view the entire ETFdb Realtime Rating, you must be an ETFdb Pro member. To see all that is included in the ETFdb Realtime Rating, see the free previews of ten of the most popular ETFs: SPY, GLD, VWO, EFA, EEM, IVV, QQQ, TIP, VTI, LQD . Please login or begin your 7-day free trial to continue reading. There are several benefits to becoming an ETFdb Pro member today:
Get valuable insight from our analysts in the ETFdb Category reports, with in-depth breakdown every ETF niche, large or small.- Get portfolio guidance on nearly every possible investor scenario and include detailed information on risk profiles, asset correlation, portfolio management, and more.
- Get access to our premium monthly newsletter ETF Edge.
- Gain access to premium research reports covering popular sectors of the ETF industry.
- Read in-depth monthly Q&A's with our Senior Analyst Michael Johnston.
- Use the ETFdb Pro Screener to screen ETFs according to your own customized parameters, then download the results in Microsoft Excel format.
- Get 100% access to the ETF Head-To-Head Comparison Tool, a resource that shows how more than 1,100 ETFs stack up against the competition in terms of performance, holdings, and technical strength.
Begin Your Free 7-Day Trial Now - or - Read more about ETFdb Pro
